Charles Schwab Investment Management Inc Ironwood Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,647,015 shares of IRWD stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,647,015
Previous 1,983,240
33.47%
Holding current value
$2.06 Million
Previous $8.79 Million
55.71%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding IRWD
# of Institutions
217Shares Held
167MCall Options Held
11.2MPut Options Held
6.9K-
Black Rock Inc. New York, NY22.9MShares$17.8 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$12.8 Million6.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$12.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY13.7MShares$10.7 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.94MShares$7.75 Million0.02% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $120M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...